Clinical Trial Update: Heterozygous Individuals for AGXT and Kidney Stones [NA]

View source ↗

Summary

A clinical trial update indicates a study investigating kidney stone risk in heterozygous AGXT carriers is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Kidney Stone | NA | Status: NOT_YET_RECRUITING